MENU
IFRX
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.27
Change
-$0.19 (-13.01%)
Capitalization
98.91M
126 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IFRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

InflaRx (IFRX) Earnings Date & Reports

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

IFRX is expected to report earnings to fall 11.06% to -16 cents per share on March 19

InflaRx IFRX Stock Earnings Reports
Q4'25
Est.
$-0.16
Q3'25
Missed
by $0.03
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.16
The last earnings report on November 10 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 3.35M shares outstanding, the current market capitalization sits at 98.91M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IFRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IFRX showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IFRX
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de